In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 tat-induced alterations in dopamine transmission

Synapse

Volumn 63, Issue 3, 2009, Pages 181-185

  Ferris, Mark J ^a,c   Frederick Duus, Danielle ^b   Fadel, Jim ^b   Mactutus, Charles F ^a   Booze, Rosemarie M ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

AIDS; DA; HIV; Microdialysis; NeuroAIDS; Tat

Indexed keywords

DOPAMINE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; HUMANS; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; WAKEFULNESS;

EID: 63049083412     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20594     Document Type: Article

References (19)

1. Aksenov MY, Hasselrot U, Bansal AK, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. 2001. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305:5-8.
2. Aksenov MY, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. 2003. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 987:1-9.
3. Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM. 2006. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: The role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27:217-228.
4. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM. 2000. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879:42-49.
5. Berger JR, Arendt G. 2000. HIV dementia: The role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14:214-221.
6. Cass WA, Harned ME, Peters LE, Nath A, Maragos WF. 2003. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Res 984:133-142.
7. Ferris MJ, Mactutus CF, Booze RM. 2008. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32:883-909.
8. Fitting S, Booze RM, Hasselrot U, Mactutus CF. 2008a. Differential long-term neurotoxicity of HIV-1 proteins in the hippocampal formation: A design-based stereological study. Hippocampus 18:135-147.
9. Fitting S, Booze RM, Mactutus CF. 2008b. Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: Differential effects on behavior and the relationship to stereology hippocampal measures. Brain Res [Epub ahead print].
10. Fitting S, Booze RM, Mactutus CF. 2006. Neonatal intrahippocampal glycoprotein 120 injection: The role of dopaminergic alterations in prepulse inhibition in adult rats. J Pharmacol Exp Ther 318:1352-1358.
11. Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM. 1992. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 570:49-53.
12. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE. 1993. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603:222-233.
13. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P. 2002. Involvement of dopamine in the progression of AIDS Dementia Complex. J Neural Transm 109:399-410.
14. Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M. 2000. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14:222-227.
15. Parsons LH, Smith AD, Justice JB, Jr. 1991. The in vivo microdialysis recovery of dopamine is altered independently of basal level by 6-hydroxydopamine lesions to the nucleus accumbens. J Neurosci Methods 40:139-147.
16. Smith AD, Justice JB. 1994. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J Neurosci Methods 54:75-82.
17. Theodore S, Cass WA, Maragos WF. 2006. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience 137: 925-935.
18. Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A. 2001. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2:3.
19. UNAIDS/WHO. 2007. AIDS Epidemic Update: December 2007. Available at http://www.unaids.org.